Health & Environmental Research Online (HERO)


Print Feedback Export to File
5024654 
Journal Article 
Adverse maternal, fetal, and postnatal effects of hexafluoropropylene oxide dimer acid (GenX) from oral gestational exposure in Sprague-Dawley rats 
Conley, JM; Lambright, CS; Evans, N; Strynar, MJ; Mccord, J; Mcintyre, BS; Travlos, GS; Cardon, MC; Medlock-Kakaley, E; Hartig, PC; Wilson, VS; Gray, LE, Jr 
2019 
Yes 
Environmental Health Perspectives
ISSN: 0091-6765
EISSN: 1552-9924 
US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE 
RES TRIANGLE PK 
127 
1-13 
English 
Hexafluoropropylene oxide dimer acid ((HFPO-DA), GenX) is a member of the per- and polyfluoroalkyl substances (PFAS) chemical class and elevated levels have been detected in surface water, air, and treated drinking water in the United States and Europe.

Objectives: Characterize the potential maternal and postnatal toxicities of oral HFPODA in rats during sexual differentiation. Given that some PFAS activate peroxisome proliferator activated receptors (PPARs), assess if HFPO-DA affects androgendependent development or interferes with estrogen, androgen, or glucocorticoid receptor activity.

Methods: Steroid receptor activity was assessed with a suite of in vitro transactivation assays and Sprague-Dawley rats were used to assess maternal, fetal, and postnatal effects of HFPO-DA exposure. Dams were dosed daily via oral gavage during male reproductive development (gestation day 14-18). We evaluated fetal testes, maternal and fetal livers, maternal serum clinical chemistry, and reproductive development of F1 animals.

Results: HFPO-DA displayed negligible in vitro receptor activity and did not impact testosterone production or expression of genes key to male reproductive development in the fetal testis; however, in vivo exposure during gestation produced higher maternal liver weights (≥62.5 mg/kg), lower maternal serum thyroid hormone and lipid profiles (≥30 mg/kg), and upregulated gene expression related to PPAR signaling pathways in maternal and fetal livers (≥1 mg/kg). Further, the pilot postnatal study indicated lower female body weight and lower weights of male reproductive tissues in F1 animals.

Conclusions: HFPO-DA exposure produced multiple effects similar to prior toxicity evaluations on PFAS, such as PFOS and PFOA, but at higher oral doses. The mean dam serum concentration from the lowest dose group was 4-fold greater than the maximum serum concentration detected in a worker in a HFPO-DA manufacturing facility. Research is needed examining the mechanisms and downstream events linked to the adverse effects of PFAS, and mixture-based studies evaluating multiple PFAS. 
United States--US; North Carolina; Receptors; Toxicity; Steroids; Testosterone; Manufacturing; Water treatment; Peroxisome proliferator-activated receptors; Drinking water; Surface water; Thyroid gland; Acids; Testes; Thyroid; Exposure; Estrogens; Body weight; Laboratory animals; Gene expression; Organic chemistry; Gestation; Perfluorooctanoic acid; Animals; Biocompatibility; Dimers; Animal tissues; Lipids; Sex differentiation; Downstream effects; Glucocorticoids 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          Other Sources
               TEDX
     Screened Studies
          Excluded
               Exclude (TIAB)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
          Other Sources
               PFAS TOX Database
     Screened Studies
          Excluded
               Exclude (TIAB)
     Not prioritized for screening
     Perfluorooctane
     Ammonium 4,8-dioxa-3H-perfluorononanoate
• GenX Chemicals (CASRN 13252-13-6 and CASRN 62037-80-3)
     LitSearch GenX Ammonium Salt: Feb 2018 - Feb 2019
          Other Sources
     LitSearch: GenX - Feb 2019-Oct 2019
          WoS
          PubMed
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          Other sources
               PFAS TOX Database
     Screened Studies
          Excluded
               Exclude (TIAB)
     Ammonium perfluoro-2-methyl-3-oxahexanoate
     Ammonium perfluorooctanoate
     Perfluoro(2-methyl-3-oxahexanoyl) fluoride
     Perfluoro-2-methyl-3-oxahexanoic acid
     Perfluorooctane
     Perfluorooctanesulfonic acid
     Perfluorooctanoic acid
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search Update (2013-2019)
          PubMed
• Yale PFAS Liver study